drugmaker

drugmaker

美 　英

• 网络制药者

例句

There was no indication whether these unnamed sources are inside the drugmaker .

文章没有提及这些匿名的信息是否来源于制药企业内部。

A spokeswoman for Swiss drugmaker Novartis said she could not confirm whether that company was working on the vaccine.

瑞士制药厂女发言人Novartis说，她不能证实那家公司疫苗是有效的。

In 2001 Novartis, a Swiss drugmaker, won approval for Gleevec, which treats chronic myeloid leukaemia by attacking another abnormal protein.

2001年瑞士的“诺华公司”获得药物Gleevec的审批，该药通过攻击另一种非正常蛋白治疗慢性髓样白血病。

Nonetheless, taking over Wyeth would cement Pfizer's position as the world's leading drugmaker.

尽管如此，并购惠氏制药将巩固辉瑞制药世界最大制药商的地位。

Pfizer ( PFE - news - people ), world's largest drugmaker, breaks up into five smaller firms.

世界最大药企辉瑞公司分裂为五个小公司。

The drugmaker consequently lowered its outlook for 2010 revenue growth and its shares fell nearly 3 percent.

这家制药公司因此调低了2010年预计收入增长率，股票下跌近3个百分点。

The right Alzheimer's drug could earn a drugmaker a lot of money.

一个有效的药物能让开发商挣不少钱。

When one drugmaker has a manufacturing problem, others rarely step in.

当一家厂商出现了制作问题时其他厂家很少介入。

Pfizer, the world's biggest drugmaker, wants to get even bigger by taking over Wyeth, a rival.

世界最大的制药商，辉瑞制药，意图收购对手惠氏制药以变得更大。

The Justice Department may spoil the drugmaker's fresh start.

司法部可能会毁了这家药厂的新开始。

Topamax is expected to bring $569 million in worldwide revenue for the diversified drugmaker in 2010, according to Thomson Reuters data.

他们将带来569万美元在全球收入的多样化的制药公司，在2010年，据汤姆森路透社数据。

GlaxoSmithKline, the U. K. 's largest drugmaker, fell 2. 2 percent to 1, 263 pence.

英国最大的制药企业葛兰素史克公司股价下跌2.2%，至1263便士。

Pfizer Inc. , the biggest drugmaker, dropped 0. 6 percent.

制药巨头辉瑞股价下跌0.

In other corporate news, shares of King Pharmaceuticals Inc. surged after Pfizer Inc. agreed to buy the drugmaker for $3. 6 billion in cash.

在其它公司的新闻中，国王药物有限公司的股票增长在辉瑞制药有限公司之后。同意以现金购买$3.6十亿。

In corporate news, shares of King Pharmaceuticals Inc. surged after Pfizer Inc. agreed to buy the drugmaker for $3. 6 billion in cash.

企业新闻方面，国王制药公司（KingPharmaceuticals）股价上涨，此前辉瑞公司同意以36亿美元现金购买国王制药。

Actelion Ltd. lost 2. 4 percent as UBS AG downgraded the Swiss drugmaker's shares.

瑞士制药公司Actelion股价下跌2.4%，此前瑞银集团下调了该公司股票评级。